Company news
ProText Mobility, Inc. news in 2017
ProText Mobility, Inc.'s news releases, calls and decks from 2017, newest first.
Protext Pharma Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance
September 20, 2017
Protext Pharma to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes
September 13, 2017
Protext Pharma CEO Discusses South Africa Cannabis License
July 13, 2017
Protext Mobility Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License
May 23, 2017
Protext Mobility Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial
May 4, 2017
Protext Mobility Announces Acquisition of Cannabis Biosciences Inc.
March 27, 2017
Protext Mobility Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes
March 7, 2017
Protext Mobility Caps Off Week of Meetings in Mauritius With Visit to State House for Meeting With President Gurib-Fakim
March 3, 2017